US debt crossed 100% of GDP, putting fresh pressure on the macro backdrop. Economist Steve Hanke called for a constitutional fix today. That backdrop sits behind every equity move right now. Futures for the Dow, S&P 500, and Nasdaq edged higher despite the headlines, as the Trump administration sidestepped a War Powers deadline.
RBLX (Roblox) is today's biggest earnings casualty. Shares crashed after a weak forward outlook. The stock had already been a target for short sellers. LIN (Linde) offered more comfort — the industrial gas giant guided Q2 adjusted EPS to $4.40–$4.50, in line with the $4.44 estimate. Earnings season rolls on with AKAM, BWA, and ALB all due in the coming days.
CAR (Avis Budget) sits at the crossroads of multiple signals today. Jefferies downgraded the stock to Hold while raising its price target to $160. That follows a massive $1.75 billion disposal by 10% owner Pentwater Capital this week. Short interest in CAR remains heavily elevated. Bulls and bears are clearly fighting over this name.
Analyst momentum in storage continued. Rosenblatt lifted WDC to $500. Susquehanna doubled its target on SNDK to $2,000. Options flow in SNDK shows the market is deeply divided — large call and put bets are both building. The stock is up 362% year-to-date.
AXSM (Axsome Therapeutics) won an FDA approval today. The regulator expanded the use of Auvelity beyond depression. That is a clean positive catalyst with no macro noise attached.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.